Next report date
Report period
Q1 2024
EPS estimate
−1.08USD
Revenue estimate
—
−69.33 MUSD
21.17 M
Om ArriVent BioPharma, Inc.
Sektor
Bransch
VD
Zheng Bin Yao
Webbplats
Huvudkvarter
Newtown Square
Employees (FY)
40
Grundat
2021
FIGI
BBG011N37VQ0
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
